CD5 deletion enhances the antitumor activity of adoptive T cell therapies. Ruchi P Patel 1 <span class=“author-sup-sepa … ← Effect of ambrisentan in patients with systemic sclerosis and mild pulmonary arterial hypertension: long-term follow-up data from EDITA study Targeting N4-acetylcytidine suppresses hepatocellular carcinoma progression by repressing eEF2-mediated HMGB2 mRNA translation. →